 | • レポートコード：D005-01034 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、結核診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。結核診断の種類別市場規模（培養、喀痰塗抹顕微鏡検査、迅速分子検査、その他）、用途別市場規模（病院、診断研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）： ・地域別グローバル市場分析 2015年-2020年 ・結核診断の北米市場（アメリカ、カナダ、メキシコ） ・結核診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・結核診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・結核診断の南米市場（ブラジル、アルゼンチン） ・結核診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：培養、喀痰塗抹顕微鏡検査、迅速分子検査、その他 ・用途別分析：病院、診断研究所、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Summary
Market Overview
The global Tuberculosis Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Tuberculosis Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Tuberculosis Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Tuberculosis Diagnostics market has been segmented into Culture-based, Sputum Smear Microscopy, Rapid Molecular, Others, etc.
By Application, Tuberculosis Diagnostics has been segmented into Hospital, Diagnostic Laboratories, Others, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Tuberculosis Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level Tuberculosis Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Tuberculosis Diagnostics market.
The report offers in-depth assessment of the growth and other aspects of the Tuberculosis Diagnostics market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Tuberculosis Diagnostics markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Tuberculosis Diagnostics Market Share Analysis
Tuberculosis Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Tuberculosis Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Tuberculosis Diagnostics sales, revenue and market share for each player covered in this report.
The major players covered in Tuberculosis Diagnostics are: Danaher, BioMerieux, BD, Roche, Qiagen, Thermo Fisher Scientific, Oxford Immunotec, Hologic, Abbott, Hain Lifescience, Epistem, Akonni Biosystems, Creative Diagnostics, etc. Among other players domestic and global, Tuberculosis Diagnostics market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Table of Contents
1 Tuberculosis Diagnostics Market Overview
1.1 Product Overview and Scope of Tuberculosis Diagnostics
1.2 Classification of Tuberculosis Diagnostics by Type
1.2.1 Global Tuberculosis Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Tuberculosis Diagnostics Revenue Market Share by Type in 2019
1.2.3 Culture-based
1.2.4 Sputum Smear Microscopy
1.2.5 Rapid Molecular
1.2.6 Others
1.3 Global Tuberculosis Diagnostics Market by Application
1.3.1 Overview: Global Tuberculosis Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Global Tuberculosis Diagnostics Market by Regions
1.4.1 Global Tuberculosis Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Tuberculosis Diagnostics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Tuberculosis Diagnostics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Tuberculosis Diagnostics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tuberculosis Diagnostics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Tuberculosis Diagnostics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tuberculosis Diagnostics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Danaher
2.1.1 Danaher Details
2.1.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Danaher SWOT Analysis
2.1.4 Danaher Product and Services
2.1.5 Danaher Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 BioMerieux
2.2.1 BioMerieux Details
2.2.2 BioMerieux Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 BioMerieux SWOT Analysis
2.2.4 BioMerieux Product and Services
2.2.5 BioMerieux Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 BD
2.3.1 BD Details
2.3.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 BD SWOT Analysis
2.3.4 BD Product and Services
2.3.5 BD Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Qiagen
2.5.1 Qiagen Details
2.5.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Qiagen SWOT Analysis
2.5.4 Qiagen Product and Services
2.5.5 Qiagen Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Thermo Fisher Scientific
2.6.1 Thermo Fisher Scientific Details
2.6.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Thermo Fisher Scientific SWOT Analysis
2.6.4 Thermo Fisher Scientific Product and Services
2.6.5 Thermo Fisher Scientific Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Oxford Immunotec
2.7.1 Oxford Immunotec Details
2.7.2 Oxford Immunotec Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Oxford Immunotec SWOT Analysis
2.7.4 Oxford Immunotec Product and Services
2.7.5 Oxford Immunotec Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Hologic
2.8.1 Hologic Details
2.8.2 Hologic Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Hologic SWOT Analysis
2.8.4 Hologic Product and Services
2.8.5 Hologic Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Abbott
2.9.1 Abbott Details
2.9.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Abbott SWOT Analysis
2.9.4 Abbott Product and Services
2.9.5 Abbott Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Hain Lifescience
2.10.1 Hain Lifescience Details
2.10.2 Hain Lifescience Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Hain Lifescience SWOT Analysis
2.10.4 Hain Lifescience Product and Services
2.10.5 Hain Lifescience Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Epistem
2.11.1 Epistem Details
2.11.2 Epistem Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Epistem SWOT Analysis
2.11.4 Epistem Product and Services
2.11.5 Epistem Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.12 Akonni Biosystems
2.12.1 Akonni Biosystems Details
2.12.2 Akonni Biosystems Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Akonni Biosystems SWOT Analysis
2.12.4 Akonni Biosystems Product and Services
2.12.5 Akonni Biosystems Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.13 Creative Diagnostics
2.13.1 Creative Diagnostics Details
2.13.2 Creative Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Creative Diagnostics SWOT Analysis
2.13.4 Creative Diagnostics Product and Services
2.13.5 Creative Diagnostics Tuberculosis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Tuberculosis Diagnostics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Tuberculosis Diagnostics Players Market Share
3.2.2 Top 10 Tuberculosis Diagnostics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Tuberculosis Diagnostics Revenue and Market Share by Regions
4.2 North America Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
4.3 Europe Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
4.5 South America Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
5 North America Tuberculosis Diagnostics Revenue by Countries
5.1 North America Tuberculosis Diagnostics Revenue by Countries (2015-2020)
5.2 USA Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
5.3 Canada Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
5.4 Mexico Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
6 Europe Tuberculosis Diagnostics Revenue by Countries
6.1 Europe Tuberculosis Diagnostics Revenue by Countries (2015-2020)
6.2 Germany Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
6.3 UK Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
6.4 France Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
6.5 Russia Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
6.6 Italy Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Tuberculosis Diagnostics Revenue by Countries
7.1 Asia-Pacific Tuberculosis Diagnostics Revenue by Countries (2015-2020)
7.2 China Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
7.3 Japan Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
7.4 Korea Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
7.5 India Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
8 South America Tuberculosis Diagnostics Revenue by Countries
8.1 South America Tuberculosis Diagnostics Revenue by Countries (2015-2020)
8.2 Brazil Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
8.3 Argentina Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Tuberculosis Diagnostics by Countries
9.1 Middle East & Africa Tuberculosis Diagnostics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
9.3 UAE Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
9.4 Egypt Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
9.5 South Africa Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Tuberculosis Diagnostics Revenue and Market Share by Type (2015-2020)
10.2 Global Tuberculosis Diagnostics Market Forecast by Type (2019-2024)
10.3 Culture-based Revenue Growth Rate (2015-2025)
10.4 Sputum Smear Microscopy Revenue Growth Rate (2015-2025)
10.5 Rapid Molecular Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Tuberculosis Diagnostics Market Segment by Application
11.1 Global Tuberculosis Diagnostics Revenue Market Share by Application (2015-2020)
11.2 Tuberculosis Diagnostics Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Diagnostic Laboratories Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Tuberculosis Diagnostics Market Size Forecast (2021-2025)
12.1 Global Tuberculosis Diagnostics Market Size Forecast (2021-2025)
12.2 Global Tuberculosis Diagnostics Market Forecast by Regions (2021-2025)
12.3 North America Tuberculosis Diagnostics Revenue Market Forecast (2021-2025)
12.4 Europe Tuberculosis Diagnostics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Tuberculosis Diagnostics Revenue Market Forecast (2021-2025)
12.6 South America Tuberculosis Diagnostics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Tuberculosis Diagnostics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Tuberculosis Diagnostics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Tuberculosis Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Tuberculosis Diagnostics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Tuberculosis Diagnostics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Danaher Corporate Information, Location and Competitors
Table 6. Danaher Tuberculosis Diagnostics Major Business
Table 7. Danaher Tuberculosis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 8. Danaher SWOT Analysis
Table 9. Danaher Tuberculosis Diagnostics Product and Solutions
Table 10. Danaher Tuberculosis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. BioMerieux Corporate Information, Location and Competitors
Table 12. BioMerieux Tuberculosis Diagnostics Major Business
Table 13. BioMerieux Tuberculosis Diagnostics Total Revenue (USD Million) (2018-2019)
Table 14. BioMerieux SWOT Analysis
Table 15. BioMerieux Tuberculosis Diagnostics Product and Solutions
Table 16. BioMerieux Tuberculosis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. BD Corporate Information, Location and Competitors
Table 18. BD Tuberculosis Diagnostics Major Business
Table 19. BD Tuberculosis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 20. BD SWOT Analysis
Table 21. BD Tuberculosis Diagnostics Product and Solutions
Table 22. BD Tuberculosis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Roche Corporate Information, Location and Competitors
Table 24. Roche Tuberculosis Diagnostics Major Business
Table 25. Roche Tuberculosis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 26. Roche SWOT Analysis
Table 27. Roche Tuberculosis Diagnostics Product and Solutions
Table 28. Roche Tuberculosis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Qiagen Corporate Information, Location and Competitors
Table 30. Qiagen Tuberculosis Diagnostics Major Business
Table 31. Qiagen Tuberculosis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 32. Qiagen SWOT Analysis
Table 33. Qiagen Tuberculosis Diagnostics Product and Solutions
Table 34. Qiagen Tuberculosis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 36. Thermo Fisher Scientific Tuberculosis Diagnostics Major Business
Table 37. Thermo Fisher Scientific Tuberculosis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 38. Thermo Fisher Scientific SWOT Analysis
Table 39. Thermo Fisher Scientific Tuberculosis Diagnostics Product and Solutions
Table 40. Thermo Fisher Scientific Tuberculosis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Oxford Immunotec Corporate Information, Location and Competitors
Table 42. Oxford Immunotec Tuberculosis Diagnostics Major Business
Table 43. Oxford Immunotec Tuberculosis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 44. Oxford Immunotec SWOT Analysis
Table 45. Oxford Immunotec Tuberculosis Diagnostics Product and Solutions
Table 46. Oxford Immunotec Tuberculosis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Hologic Corporate Information, Location and Competitors
Table 48. Hologic Tuberculosis Diagnostics Major Business
Table 49. Hologic Tuberculosis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 50. Hologic SWOT Analysis
Table 51. Hologic Tuberculosis Diagnostics Product and Solutions
Table 52. Hologic Tuberculosis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Abbott Corporate Information, Location and Competitors
Table 54. Abbott Tuberculosis Diagnostics Major Business
Table 55. Abbott Tuberculosis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 56. Abbott SWOT Analysis
Table 57. Abbott Tuberculosis Diagnostics Product and Solutions
Table 58. Abbott Tuberculosis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Hain Lifescience Corporate Information, Location and Competitors
Table 60. Hain Lifescience Tuberculosis Diagnostics Major Business
Table 61. Hain Lifescience Tuberculosis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 62. Hain Lifescience SWOT Analysis
Table 63. Hain Lifescience Tuberculosis Diagnostics Product and Solutions
Table 64. Hain Lifescience Tuberculosis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Epistem Corporate Information, Location and Competitors
Table 66. Epistem Tuberculosis Diagnostics Major Business
Table 67. Epistem Tuberculosis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 68. Epistem SWOT Analysis
Table 69. Epistem Tuberculosis Diagnostics Product and Solutions
Table 70. Epistem Tuberculosis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Akonni Biosystems Corporate Information, Location and Competitors
Table 72. Akonni Biosystems Tuberculosis Diagnostics Major Business
Table 73. Akonni Biosystems Tuberculosis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 74. Akonni Biosystems SWOT Analysis
Table 75. Akonni Biosystems Tuberculosis Diagnostics Product and Solutions
Table 76. Akonni Biosystems Tuberculosis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Creative Diagnostics Corporate Information, Location and Competitors
Table 78. Creative Diagnostics Tuberculosis Diagnostics Major Business
Table 79. Creative Diagnostics Tuberculosis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 80. Creative Diagnostics SWOT Analysis
Table 81. Creative Diagnostics Tuberculosis Diagnostics Product and Solutions
Table 82. Creative Diagnostics Tuberculosis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Tuberculosis Diagnostics Revenue (Million USD) by Players (2015-2020)
Table 84. Global Tuberculosis Diagnostics Revenue Share by Players (2015-2020)
Table 85. Global Tuberculosis Diagnostics Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Tuberculosis Diagnostics Revenue Market Share by Regions (2015-2020)
Table 87. North America Tuberculosis Diagnostics Revenue by Countries (2015-2020)
Table 88. North America Tuberculosis Diagnostics Revenue Market Share by Countries (2015-2020)
Table 89. Europe Tuberculosis Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Tuberculosis Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Tuberculosis Diagnostics Revenue by Countries (2015-2020)
Table 92. South America Tuberculosis Diagnostics Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Tuberculosis Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Tuberculosis Diagnostics Revenue Market Share by Countries (2015-2020)
Table 95. Global Tuberculosis Diagnostics Revenue (Million USD) by Type (2015-2020)
Table 96. Global Tuberculosis Diagnostics Revenue Share by Type (2015-2020)
Table 97. Global Tuberculosis Diagnostics Revenue Forecast by Type (2021-2025)
Table 98. Global Tuberculosis Diagnostics Revenue by Application (2015-2020)
Table 99. Global Tuberculosis Diagnostics Revenue Share by Application (2015-2020)
Table 100. Global Tuberculosis Diagnostics Revenue Forecast by Application (2021-2025)
Table 101. Global Tuberculosis Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Tuberculosis Diagnostics Picture
Figure 2. Global Tuberculosis Diagnostics Revenue Market Share by Type in 2019
Figure 3. Culture-based Picture
Figure 4. Sputum Smear Microscopy Picture
Figure 5. Rapid Molecular Picture
Figure 6. Others Picture
Figure 7. Tuberculosis Diagnostics Revenue Market Share by Application in 2019
Figure 8. Hospital Picture
Figure 9. Diagnostic Laboratories Picture
Figure 10. Others Picture
Figure 11. Global Tuberculosis Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Tuberculosis Diagnostics Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Tuberculosis Diagnostics Revenue Market Share in 2019
Figure 20. Global Top 10 Players Tuberculosis Diagnostics Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Tuberculosis Diagnostics Revenue Market Share by Regions (2015-2020)
Figure 24. Global Tuberculosis Diagnostics Revenue Market Share by Regions in 2018
Figure 25. North America Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 26. Europe Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 28. South America Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 30. North America Tuberculosis Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 31. North America Tuberculosis Diagnostics Revenue Market Share by Countries in 2019
Figure 32. USA Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 33. Canada Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 35. Europe Tuberculosis Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Tuberculosis Diagnostics Revenue Market Share by Countries in 2019
Figure 37. Germany Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 38. UK Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 39. France Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 40. Russia Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 41. Italy Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Tuberculosis Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Tuberculosis Diagnostics Revenue Market Share by Countries in 2019
Figure 44. China Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 45. Japan Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 46. Korea Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 47. India Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 49. South America Tuberculosis Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 50. South America Tuberculosis Diagnostics Revenue Market Share by Countries in 2019
Figure 51. Brazil Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Tuberculosis Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Tuberculosis Diagnostics Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 56. UAE Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Tuberculosis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 59. Global Tuberculosis Diagnostics Revenue Share by Type (2015-2020)
Figure 60. Global Tuberculosis Diagnostics Revenue Share by Type in 2019
Figure 61. Global Tuberculosis Diagnostics Market Share Forecast by Type (2021-2025)
Figure 62. Global Culture-based Revenue Growth Rate (2015-2020)
Figure 63. Global Sputum Smear Microscopy Revenue Growth Rate (2015-2020)
Figure 64. Global Rapid Molecular Revenue Growth Rate (2015-2020)
Figure 65. Global Others Revenue Growth Rate (2015-2020)
Figure 66. Global Tuberculosis Diagnostics Revenue Share by Application (2015-2020)
Figure 67. Global Tuberculosis Diagnostics Revenue Share by Application in 2019
Figure 68. Global Tuberculosis Diagnostics Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospital Revenue Growth Rate (2015-2020)
Figure 70. Global Diagnostic Laboratories Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Tuberculosis Diagnostics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Tuberculosis Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Tuberculosis Diagnostics Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Tuberculosis Diagnostics Revenue Market Forecast (2021-2025)
Figure 76. Europe Tuberculosis Diagnostics Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Tuberculosis Diagnostics Revenue Market Forecast (2021-2025)
Figure 78. South America Tuberculosis Diagnostics Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Tuberculosis Diagnostics Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
結核薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tuberculosis Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.8% in the forecast period of 2020 to 2025 and will expected to reach USD 965.3 million by 2025, from USD 863.6 million in 2019. The Tuberculosis Drugs …- 結核治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Tuberculosis Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.8% in the forecast period of 2020 to 2025 and will expected to reach USD 965.3 million by 2025, from USD 863.6 million in 2019. The Tuberculosis…
- 結核治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tuberculosis Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tuberculosis Tre…
- 結核ワクチン治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Tuberculosis Vaccine Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tuberculosis V…
- 結核診断＆治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Tuberculosis Diagnosis and Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tubercul…